Showing results (281-290 of 446) with videos related to

Sort By:
Pageof 45
Cancers|May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced MelanomaKrisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
JCO Precision Oncology|February 9, 2022
Effects of Molecular Heterogeneity on Survival of Patients With BRAFV600-Mutated Melanoma Treated With Vemurafenib With or Without Cobimetinib in the coBRIM StudyMatthew J Wongchenko, Antoni Ribas, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Cancer Cell|August 16, 2011
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stromaVictoria Sanz-Moreno, Cedric Gaggioli, Maggie Yeo, et al.
JCO Precision Oncology|February 9, 2022
Elevated Levels of BRAF Mutant Circulating Tumor DNA and Circulating Hepatocyte Growth Factor Are Associated With Poor Prognosis in Patients With Metastatic MelanomaWilliam Lu, Luciana Burton, James Larkin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer|July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V Long, Hao Tang, Keyur Desai, et al.
Clinical Kidney Journal|October 1, 2025
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysisBrett Duane, James Larkin, Marialuisa Caiazzo, et al.
International Urology and Nephrology|February 3, 2026
Comparing environmental footprints of haemodialysis and online haemodiafiltration in ItalyJames Larkin, Giulia Ligabue, Niccolo Morisi, et al.
Cancers|August 14, 2025
Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT StudyJavier Pozas, Sowmya Cheruvu, Poorni Priya Jaganathan, et al.
Pageof 45